These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 19295412)

  • 21. Optimizing anemia management in hospitalized patients with end-stage renal disease.
    Heung M; Mueller BA; Segal JH
    Ann Pharmacother; 2009 Feb; 43(2):276-82. PubMed ID: 19141655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. It's time to compare anemia management strategies in hemodialysis.
    Coyne DW
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):740-2. PubMed ID: 20299363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of anemia correction with health related quality of life in patients not on dialysis.
    Alexander M; Kewalramani R; Agodoa I; Globe D
    Curr Med Res Opin; 2007 Dec; 23(12):2997-3008. PubMed ID: 17958944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dosing intervals and hemoglobin control in patients with chronic kidney disease and anemia treated with epoetin alfa or darbepoetin alfa: a retrospective cohort study.
    Nurko S; Spirko R; Law A; Dennis VW
    Clin Ther; 2007 Sep; 29(9):2010-21. PubMed ID: 18035200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of darbepoetin alfa on renal anemia in Japanese hemodialysis patients.
    Kusaba T; Ishida R; Nakayama M; Kato H; Uchiyama H; Sato K; Mori Y; Matsubara H; Kajita Y
    Arzneimittelforschung; 2009; 59(9):435-9. PubMed ID: 19856789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimization of anemia treatment in hemodialysis patients via reinforcement learning.
    Escandell-Montero P; Chermisi M; Martínez-Martínez JM; Gómez-Sanchis J; Barbieri C; Soria-Olivas E; Mari F; Vila-Francés J; Stopper A; Gatti E; Martín-Guerrero JD
    Artif Intell Med; 2014 Sep; 62(1):47-60. PubMed ID: 25091172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Definition and Validation of a Novel Metric of Erythropoiesis-Stimulating Agent Response in Hemodialysis Patients.
    Meaney CJ; Karas S; Robinson B; Gaesser J; Forrest A; Krzyzanski W; Panesar M; Rao GG
    J Clin Pharmacol; 2019 Mar; 59(3):418-426. PubMed ID: 30412269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Should the target hemoglobin for patients with chronic kidney disease treated with erythropoietic replacement therapy be changed?
    Berns JS
    Semin Dial; 2005; 18(1):22-9. PubMed ID: 15663760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Practical approach to the diagnosis and treatment of anemia associated with CKD in elderly.
    Agarwal AK
    J Am Med Dir Assoc; 2006 Nov; 7(9 Suppl):S7-S12; quiz S17-21. PubMed ID: 17098634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Initiation of anaemia management in patients with chronic kidney disease not on dialysis in the Veterans Health Administration.
    Lawler EV; Gagnon DR; Fink J; Seliger S; Fonda J; Do TP; Gaziano JM; Bradbury BD
    Nephrol Dial Transplant; 2010 Jul; 25(7):2237-44. PubMed ID: 20083469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simplifying anemia management in hemodialysis patients: ESAs administered at longer dosing intervals can enhance opportunities to provide patient-focused care.
    Schiller B; Besarab A
    Curr Med Res Opin; 2011 Aug; 27(8):1539-50. PubMed ID: 21682552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cost effectiveness of erythropoietin-stimulating agents for treating anemia in patients on dialysis: a systematic review.
    Ferguson T; Xu Y; Gunasekara R; Lerner B; Macdonald K; Rigatto C; Tangri N; Komenda P
    Am J Nephrol; 2015; 41(2):89-97. PubMed ID: 25721696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in erythropoiesis-stimulating agent (ESA) dosing and haemoglobin levels in US non-dialysis chronic kidney disease patients between 2005 and 2009.
    Regidor D; McClellan WM; Kewalramani R; Sharma A; Bradbury BD
    Nephrol Dial Transplant; 2011 May; 26(5):1583-91. PubMed ID: 20861195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of the change in CMS billing rules for erythropoietin on hemoglobin outcomes in dialysis patients.
    Ofsthun NJ; Lazarus JM
    Blood Purif; 2007; 25(1):31-5. PubMed ID: 17170534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammation, high ferritin, and erythropoietin resistance in indigenous maintenance hemodialysis patients from the Top End of Northern Australia.
    Majoni SW; Ellis JA; Hall H; Abeyaratne A; Lawton PD
    Hemodial Int; 2014 Oct; 18(4):740-50. PubMed ID: 24766376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A vitamin E-coated polysulfone membrane reduces serum levels of inflammatory markers and resistance to erythropoietin-stimulating agents in hemodialysis patients: results of a randomized cross-over multicenter trial.
    Panichi V; Rosati A; Paoletti S; Ferrandello P; Migliori M; Beati S; Bernabini G; Daini R; Casani A; Angelini D; Parrini M; Rossi A; Petrone I; Barsotti G; Donadio C; Donati G; Grazi G; Manca Rizza G; Garosi G; Sansoni E; Braccagni B; Sidoti A; Boracelli D; Biagioli M; Moriconi L; Finato V; Mannarino A; Grimaldi C; Pansa F; Imperiali P; Mura C; Bianchi S; Bigazzi R
    Blood Purif; 2011; 32(1):7-14. PubMed ID: 21242686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health-related quality of life and hemoglobin levels in chronic kidney disease patients.
    Finkelstein FO; Story K; Firanek C; Mendelssohn D; Barre P; Takano T; Soroka S; Mujais S
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):33-8. PubMed ID: 18987300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The optimal hemoglobin in dialysis patients- a critical review.
    Singh AK; Fishbane S
    Semin Dial; 2008; 21(1):1-6. PubMed ID: 18251947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythropoietic response and outcomes in kidney disease and type 2 diabetes.
    Solomon SD; Uno H; Lewis EF; Eckardt KU; Lin J; Burdmann EA; de Zeeuw D; Ivanovich P; Levey AS; Parfrey P; Remuzzi G; Singh AK; Toto R; Huang F; Rossert J; McMurray JJ; Pfeffer MA;
    N Engl J Med; 2010 Sep; 363(12):1146-55. PubMed ID: 20843249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of hemoglobin variability and mortality among contemporary incident hemodialysis patients.
    Brunelli SM; Lynch KE; Ankers ED; Joffe MM; Yang W; Thadhani RI; Feldman HI
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1733-40. PubMed ID: 18922985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.